The Global Cell Therapy market is due to grow at a CAGR of 10.6% during the forecast period of 2017 to 2023 according to Market Research Future’s latest report on the subject. Cell therapy has emerged as a transformative field in biotechnology due to its use for the targeting of various diseases at a cellular level. The above-average growth expected by this market will primarily be due to the rapidly advancing healthcare sector and growing breakthrough research and development activities.

Cell therapy is finding a growing number of applications in healthcare and is often used in combination with gene therapy. Presently, applications of cell therapy include urinary problems, cancers, autoimmune disease, and infectious disease among several others. The growing prevalence of chronic and lifestyle diseases is an important driver for the cell therapy market. Cell therapy is also being developed in regenerative medicine which carries massive potential once it clears the research phase. Increasing geriatric population with health issues and technological advancements are some other factors governing market growth. government assistance for research and improvements being made in existing regulatory frameworks are expected to pave the way for future market opportunities.

However, it should be noted that the high cost of manufacturing at present and the lack of awareness or appropriate healthcare infrastructure are expected to challenge market growth.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5066

The Cell therapy market is expected to grow at a CAGR 10.6% during the forecast period of 2017-2023.

A number of factors such as increasing geriatric population, increasing government assistance, replacement of animal testing model, technological advancements, and improvement in the regulatory framework, are propelling the growth of cell therapy market. Rising prevalence of chronic disorders is also fuelling up the market to a great extent.

Despite these drivers, there are some issues associated with cell therapy market. Challenges in research and development, the high cost of manufacturing, and poor healthcare system in low and middle-income countries may hamper the growth of the market.

Cell Therapy Market Major Key Players

Novartis AG
GlaxoSmithKline plc
MEDIPOST
Osiris
PHARMICELL
NuVasive, Inc.
JCR Pharmaceuticals Co., Ltd
ANTEROGEN.CO.,LTD.
Cynata
CELLECTIS
BioNTech IMFS
EUFETS GmbH
Cognate
PluristemGrupo Praxis
Genzyme Corporation
Advanced Tissue and others.
Cell Therapy Market Segmentation

The cell therapy market is segmented on the basis of type, technology, cell source, application, and end-user.

On the basis of type, the market is segmented into autologous, and allogeneic.

On the basis of technology, the market is classified into somatic cell technology, cell immortalization technology, viral vector technology, genome editing technology, cell plasticity technology, and three-dimensional technology. Viral vector technology is further segmented into Ex vivo gene modification of cells and In vivo gene modification of cells.

On the basis of cell source, the market is classified into induced pluripotent stem cells (iPSCs), bone marrow, umbilical cord blood-derived cells, adipose tissue, and neural stem cell.

On the basis of application, the market is classified into musculoskeletal, cardiovascular, gastrointestinal, neurological, oncology, dermatology, wounds and injuries, ocular, and others.

On the basis of end-users, the market is segmented into hospital & clinics, regenerative medicine centers, diagnostic centers, research institutes, and others.

Cell Therapy Market Regional Analysis

The Americas dominate the cell therapy market owing to the rise in awareness among people, and high healthcare expenditure.

Europe holds the second position in cell therapy market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region. On August 30, 2017. Novartis AG, A Switzerland based market leader, received FDA approval for Kymriah suspension for intravenous infusion. It is the first chimeric antigen receptor T cell therapy (CAR-T).

The Asia Pacific is the fastest growing cell therapy market owing to the huge patient pool and developing healthcare technology.

Browse Complete 85 Pages Premium Research Report Enabled with 88 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cell-therapy-market-5066

Detailed Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

…Continued



About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]